April 24, 2017
11 am to 12 pm EDT
Actionable biomarkers can be the difference between a successful and unsuccessful product launch in the Pharmaceutical industry. Translational scientists often invest tremendous effort in the collection and curation of data leaving little time for
analysis. The need to analyze large volumes of complex genomic and phenotypic data quickly and accurately is critical to the discovery of new and actionable biomarkers. The analyses are often very complex and require programming skills or other
specialty skills to complete the work. In this webinar, PerkinElmer Informatics will outline data analytics workflows to simplify this process and expedite Translational research.
- Translational data can be immediately made available for analysis
- Enable scientists to complete complicated, in-depth analyses without the need for specialty skills
- Deliver Biomarker projects in half the time for greater impact on the bottom line.
Sr. Product Manager
Dave is a Senior Product Manager at PerkinElmer and leads product development for translational medicine products. Prior to PerkinElmer, Dave spent over ten years working with translational scientists and researchers building custom solutions to address
the specific needs around secondary analysis of clinical trial, genomic, and clinical data for drug discovery. Most recently, Dave was a Sr. Solutions Architect with Converge HEALTH by Deloitte leading efforts to design and implement enterprise-level
solutions for Life science, pharmaceutical, and federal clients in this space. As part of those efforts, Dave has been a member of the tranSMART foundation and helped drive the roadmap in that community.
Sr. Analytics Solution Architect
Alberto Pascual is a Doctor in Bioinformatics with a long experience in the biomedical domain. Graduated in Computer Science Engineer he received a PhD on Bioinformatics in 2002 from the Autonomous University of Madrid. He spent some Postdoc time
at the KEY Institute for Brain-Mind Research in Zurich working on Neuroinformatics. In 2004 he joined the Computer Architecture Department at the Complutense University of Madrid and in 2009 he joined the National Center for Biotechnology (CNB)
as a senior researcher, leading a bioinformatics Research and Core facility group. Alberto Pascual was one of the founders of Integromics, a Bioinformatics company that started in 2003. The company received the Frost and Sullivan European Bioinformatics
Project of the Year Award for 2007. Integromics provided state-of-the-art bioinformatics software solutions for data management and data analysis in genomics and proteomics using TIBCO Spotfire® as its development platform. Alberto mix of
backgrounds includes Business Intelligence, Biostatistics, Machine learning, Bioinformatics, Computational Biology among others. He also published more than 70 papers in peer-review high-impact journals. Currently he is working as Senior Analytics
Solution architect in R+D Organization at Perkin Elmer Informatics developing innovative bioinformatics and analytical applications in the context of Translation Medicine, Screening, Imaging, Clinical, Manufacturing and other analytical areas.